Keeping the Body Mind: A lifestyle intervention for young people with first episode psychosis

Not Applicable

Completed

• Conditions: First Episode Psychosis; Mental Health - Psychosis and personality disorders

• Registration Number: ACTRN12613001217796
• Lead Sponsor: Bondi Early Pscyhosis Programme

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All clients referred to the Bondi Early Psychosis Program meeting required eligibility criteria will be automatically referred to the KBIM lifestyle intervention. To be eligible for referral to KBIM clients must be experiencing a FEP, defined as a schizophreniform psychosis schizophrenia, schizoaffective disorder, delusional disorder, brief psychotic disorder, substance induced psychotic disorder or affective disorders (bipolar, depression) with psychotic features according to DSM-IV-TR criteria, and receiving treatment with anti-psychotic medication.

Exclusion Criteria

Clients will be ineligible to participate in the trial if they are medically unfit to exercise, or if they have had previous anti-psychotic exposure greater than or equivalent to four weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
body weight (kg) is measured whilst clients are barefoot using digital scales.[baseline, week 12]

Secondary Outcome Measures

Name	Time	Method
Waist circumference (cm) will be measured using a tape measure with clients wearing loose fitting clothing[baseline, week 12];body mass index (BMI) will be calculated using height and weight. A stadiometer will be used to record weight with clients bare-foot[baseline, week 12];blood pressure (mmHg) will be recorded manually using a sphygmomanometer and stethoscope [baseline, week 12];lipid profile (HDL,LDL, triglycerides, total cholesterol); all participants will be provided with pathology forms to be taken to private pathology collection facilities[baseline, week 12];blood glucose levels (mmol/L); all participants will be provided with pathology forms to be taken to private pathology collection facilities[baseline, week 12]